Why the need for enhanced protection for CIED procedures?
The incidence of infection associated with cardiac implantable electronic devices (CIED) is gaining in number due to the widespread use of device therapy of bradycardia, tachycardia and heart insufficiency.
Why the need for enhanced protection for CIED procedures?
The incidence of infection associated with cardiac implantable electronic devices (CIED) is gaining in number due to the widespread use of device therapy of bradycardia, tachycardia and heart insufficiency.
There is an increasing use of different CIED modalities. Worldwide, the use of more complex CIED's such as biventricular pacemakers for cardiac resynchronization therapy (CRT) and implantable cardioverter defibrillators (ICD) - thus increasing numbers of pacemaker leads in each patient - have led to a growing risk of complications such as infections, accounting for over 80% of complications.
Bacterial infection is one of the most common causes of CIED complications - and it is on the rise.
CIED infections continue to occur and can be life threatening…they are in fact associated with increased mortality.
Professional and hospital performance is increasingly under surveillance, by both national institutions and patients.
- Physician Quality Reporting Systems to monitor quality management and quality assurance are already mandatory in the US, UK, Germany and other countries worldwide.
- Infection associated costs are imposed on the facility in Germany, NIH in the US goes one step further - reimbursement is linked to reporting on performance measures. Hospital acquired infections lead to a lesser reimbursement!
CIED infection is expensive and time consuming!
- CIED infections are associated with a need for prolonged hospitalization to ensure sufficient antibiotic treatment and subsequent device removal.
- The risk adjusted average length of stay with CIED infection is 15,5 to 24,3 days in the US
- The risk adjusted average length of stay with CIED infection is 17 to 22 days in the UK
- The economic burden including healthcare resource utilization of CIED infections is substantial
- In 2011, the average cost of combined medical and surgical treatment for a single CIED infection in the US ranged between $28,676 and $53,349.
- A 2019 study reported the average cost of CIED infection in the UK to ranging from £ 5.130,20 in case of PPM infection up to £.24.315,80 in case of CRT-D infection.
close
